CX 2021 Programme


Search for words

Peripheral Arterial Proximal Controversies - Tuesday, 20th April
Venue:   Livestream 1
Time: 14:00 - 19:30 London time (BST)
Paclitaxel-coated device controversies
Time: 14:00 - 15:00 London time (BST)
Moderators:   Andrew Holden, Auckland, New Zealand
Gunnar Tepe, Rosenheim, Germany
14:00 - 14:05
Five-year mortality in the REAL-PTX study
Speaker:   Sabine Steiner, Leipzig, Germany
14:05 - 14:10
Audience participation and discussion
14:10 - 14:15
Latest analysis and interpretation of SWEDEPAD trial concerning mortality
Speaker:   Mårten Falkenberg, Gothenburg, Sweden
14:15 - 14:20
Audience participation and discussion
14:20 - 14:25
Limus is the better drug for prevention of restenosis in peripheral interventions
Speaker:   Edward Choke, Singapore, Singapore
14:25 - 14:30
Audience participation and discussion
14:30 - 14:35
Clinical evaluation and regulatory approaches to next-generation drug-coated devices for peripheral arterial disease
Speaker:   Sara Royce, FDA, Silver Spring, United States
14:35 - 14:40
Audience participation and discussion
14:40 - 14:45
MHRA regulatory update on paclitaxel DBC and DES to date
Speaker:   Roopa Prabhakar, MHRA, London, United Kingdom
14:45 - 14:50
Audience participation and discussion
14:50 - 14:55
It is time to change the agency recommendations regarding paclitaxel use in peripheral interventions
Speaker:   Thomas Zeller, Bad Krozingen, Germany
14:55 - 15:00
Audience participation and discussion
 
Networking break
Time: 15:00 - 15:30 London time (BST)
Satellite Symposium: Sirolimus-coated balloon: What the future holds for PAD
Time: 15:00 - 15:30 London time (BST)
Moderator:   Sahil Parikh, New York, United States
15:00 - 15:06
Sirolimus-coated balloon with Nanolute technology - prospect and appraisal over paclitaxel, insights from the latest pre-clinical data
Speaker:   Aloke Finn, Gaithersburg, United States
15:06 - 15:14
One-year results of the XTOSI trial for SFA and BTK disease
Speaker:   Edward Choke, Singapore, Singapore
15:14 - 15:20
SirPAD - The largest randomised trial with a sirolimus-coated balloon for peripheral arterial disease treatment
Speaker:   Nils Kucher, Zurich, Switzerland
15:20 - 15:30
Audience participation, discussion and conclusion
 
Podium 1st miscellaneous controversies
Time: 15:30 - 16:30 London time (BST)
Moderators:   Thomas Zeller, Bad Krozingen, Germany
Robert Hinchliffe, Bristol, United Kingdom
15:30 - 15:35
Podium 1st: Five-year meta-analysis including mortality update with FDA-approved RCTs of paclitaxel devices
Speaker:   Andrew Holden, Auckland, New Zealand
15:35 - 15:40
Audience participation and discussion
15:40 - 15:45
Podium 1st: IVUS vs. angiography-guided femoropopliteal revascularisation: Twelve-month results from a randomised controlled trial
Speaker:   Phillip Puckridge, Marion, Australia
15:45 - 15:50
Audience participation and discussion
15:50 - 15:55
Podium 1st: Comparison of swirling flow stent and drug-eluting device outcomes
Speaker:   Peter Gaines, Sheffield, United Kingdom
15:55 - 16:00
Audience participation and discussion
16:00 - 16:05
Podium 1st: ZILVERPASS 36-month data update
Speaker:   Michel Bosiers, Muenster, Germany
16:05 - 16:10
Audience participation and discussion
16:10 - 16:15
Podium 1st: Five-year outcomes with DCB alone versus DCB plus stenting from the IN.PACT Global Study
Speaker:   Gary Ansel, Columbus, United States
16:15 - 16:20
Audience participation and discussion
16:20 - 16:25
Podium 1st: Five-year results from a patient-level meta-analysis of the ILLUMENATE RCTs
Speaker:   WIlliam Gray, Wynnewood, United States
16:25 - 16:30
Audience participation and discussion
 
Networking break
Time: 16:30 - 17:00 London time (BST)
Satellite Symposium: Occlusive Iliac artery pathology: Guidelines, treatment algorithms and gaps
Time: 16:30 - 17:00 London time (BST)
Moderator:   Michele Piazza, Padua, Italy
16:30 - 16:35
Treatment approach for iliac occlusive disease (VSX): What is the best option? Experience and data
Speaker:   Manuel Alonso Perez, Oviedo, Spain
16:35 - 16:40
Audience participation and discussion
16:40 - 16:45
Case presentation and experience
Speaker:   Lukasz Dzieciuchowicz, Poznan, Poland
16:45 - 16:50
Audience participation and discussion
16:50 - 16:55
Case presentation and experience
Speaker:   Alexander Oberhuber, Dusseldorf, Germany
16:55 - 17:00
Audience participation and discussion
 
Reconstruction controversies
Time: 17:00 - 17:50 London time (BST)
Moderators:   Thomas Zeller, Bad Krozingen, Germany
Andrew Holden, Auckland, New Zealand
17:00 - 17:05
FLEX study: Three-year follow-up of patients with iIliac occlusive disease treated with a balloon-expandable endoprosthesis
Speaker:   Jean Panneton, Norfolk, United States
17:05 - 17:10
Audience participation and discussion
17:10 - 17:15
Edited case: Complex occlusive iliac recanalisation
Speaker:   Rutger Lelij, Amsterdam, Netherlands
17:15 - 17:20
Audience participation and discussion
17:20 - 17:25
VANQUISH trial: One-year results of heparin-bonded stent graft for femoropopliteal disease - results and factors influencing outcomes
Speaker:   Osamu Iida, Amagasaki, Japan
17:25 - 17:30
Audience participation and discussion
17:30 - 17:35
Edited case: Long SFA endoluminal bypass treatment for in-stent restenosis
Speaker:   Koen Deloose, Dendermonde, Belgium
17:35 - 17:40
Audience participation and discussion
17:40 - 17:50
CX Debate: For symptomatic origin of profunda femoris artery lesions endovascular reconstruction is indicated

For the motion
17:40 - 17:45
Rebeca Reachi-Lugo, SAN LUIS POTOSI, Mexico

Against the motion
17:45 - 17:50
Robert Hinchliffe, Bristol, United Kingdom

17:40 - 17:50
Audience participation, discussion and polling
 
Networking break
Time: 18:00 - 18:30 London time (BST)
Satellite Symposium: Reality check on treatment strategies for challenging femoropopliteal lesions: Insights from experts
Time: 18:00 - 18:30 London time (BST)
Moderator:   Koen Deloose, Dendermonde, Belgium
18:00 - 18:02
Introduction
Speaker:   Koen Deloose, Dendermonde, Belgium
18:02 - 18:12
Tips and techniques for improved outcomes: Recorded live case
Speaker:   Thomas Zeller, Bad Krozingen, Germany
18:12 - 18:20
A case example for approaching calcified lesions
Speaker:   Ralf Langhoff, Berlin, Germany
18:20 - 18:28
Audience participation and discussion
18:28 - 18:30
Closing remarks
Speaker:   Koen Deloose, Dendermonde, Belgium
 
Calcification controversies
Time: 18:30 - 19:30 London time (BST)
Moderators:   Andrew Holden, Auckland, New Zealand
Gunnar Tepe, Rosenheim, Germany
18:30 - 18:35
Early suspicion of calcified artery
Speaker:   Mari Murumets, London, United Kingdom
18:35 - 18:40
Audience participation and discussion
18:40 - 18:45
Intravascular lithotripsy for the treatment of severely calcified long lesions: Results from the DISRUPT PAD III observational study
Speaker:   Peter Soukas, Boston, United States
18:45 - 18:50
Audience participation and discussion
18:50 - 18:55
Edited case: Complex CLTI patient treated with mechanical atherothrombectomy and drug-coated balloon
Speaker:   Bruno Migliara, Peschiera, Italy
18:55 - 19:00
Audience participation and discussion
19:00 - 19:05
Edited case: When balloons will not pass is atherectomy the answer?
Speaker:   Richard O'Neill, Nottingham, United Kingdom
19:05 - 19:10
Audience participation and discussion
19:10 - 19:15
Vessel preparation for long, calcified femoropopliteal lesions with directional atherectomy and DCB: REALITY trial 12-month results
Speaker:   Krishna Rocha-Singh, Springfield, United States
19:15 - 19:20
Audience participation and discussion
19:20 - 19:25
Dissection repair: Evidence review and learnings from the TOBA trials
Speaker:   Michael Lichtenberg, Arnsberg, Germany
19:25 - 19:30
Audience participation and discussion
 
Meet the Experts session: Proven heparin bonding technology on leading prosthetic vascular graft
Time: 19:30 - 20:00 London time (BST)
Speaker:   Peter Gunnarsson, Sweden
Meet the Experts session: DCB safety in the SFA - discussion of the latest clinical data
Time: 19:30 - 20:00 London time (BST)
Moderator:   Michael Lichtenberg, Arnsberg, Germany
19:30 - 19:35
Review of a DCB clinical programme
Speaker:   Marianne Brodmann, Graz, Austria
19:35 - 19:43
Review of a DCB Syntactx independent safety analysis and conclusions
Speaker:   Kenneth Ouriel, New York, United States
19:43 - 19:50
No mortality increase with paclitaxel-coated devices in lower limb arterial procedures - an interim report of SWEDEPAD RCT data
Speaker:   Joakim Nordanstig, Molndal, Sweden
19:50 - 20:00
Panel discussion